Scientists at Columbia University in New York City found the new boosters did not produce a better antibody response in humans against BA.5 than the first-generation vaccines. A separate study by scientists at Harvard essentially came to the same conclusion. ........Dr. Paul Offit, a member of the FDA’s independent vaccine advisory committee, said public health officials should be cautious about overselling the shots as a major upgrade.
“We have to be careful when we get in front of the American public and try and sell this vaccine as something that’s significantly better when all the evidence we have so far doesn’t support that,” said Offit, an infectious disease expert at Children’s Hospital of Philadelphia, who worked on the team that developed the rotavirus vaccine.
No comments:
Post a Comment